Giuffre Randall Michael

Giuffre Randall Michael is listed in filings as Director at DiaMedica Therapeutics Inc.. This profile follows SEC Form 4 activity through Jan 6, 2026, including 5 public disclosures. Recent filings connect the profile to DiaMedica Therapeutics Inc. (DMAC). The current snapshot covers public activity from Jan 3, 2025 to Jan 6, 2026. Reported amounts are shown as $52.0K to $25.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.